CDK12 and metastatic prostate carcinoma: What’s more, it was reported that ATM, PTEN in metastatic prostate cancer had a higher mutation frequency in Blacks and Whites than in Asians, and TP53, CDK12 in primary prostate cancer had a higher mutation frequency in Whites and Asians than in Blacks [16].